Exclusion of the phosphatidylinositol-specific phospholipase C β3 (PLC β3) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene

Human Genetics

Volumn 99, Issue 1, 1996, Pages 133-137

  De Wit, Mireille J ^a   Landsvater, Rudy M ^a   Sinke, Richard J ^b   Van Kessel, Ad Geurts ^b   Lips, Cornelis J M ^a   Höppener, Jo W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C;

ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; ENDOCRINE GLAND; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; HUMAN; HUMAN CELL; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 0031060691     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050327     Document Type: Article

References (13)

1. Carozzi AJ, Kriz RW, Webster C, Parker PJ (1992) Identification, purification and characterization of a novel phosphatidylinositol-specific phospholipase C, a third member of the β subfamily. Eur J Biochem 210:521-529
2. Katan M, Kriz R, Totty N, Philp R, Meldrum E, Aldape RA, Knopf JL, Parker PJ (1988) Determination of the primary structure of PLC-154 demonstrates diversity of phosphoinositide-specific phospholipase C activities. Cell 54:171-177
3. Knudson AG (1985) Hereditary cancer, oncogenes and anti-oncogenes. Cancer Res 45:1437-1443
4. Lagercrantz J, Carson E, Phelan C, Grimmond S, Rosen A, Daré E, Nordenskjöld M, Hayward NK, Larsson C, Weber G (1995) Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C β3 gene. Genomics 26:467-472
5. Landsvater RM, Jansen RPM, Hofstra RMW, Buys CHCM, Lips CJM, Ploos van Amstel HK (1996) Mutation analysis of the Ret proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A. Hum Genet 97:11-14
6. Larsson C, Nordenskjöld M (1990) Multiple endocrine neoplasia. Cancer Surv 9:703-723
7. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87
8. Larsson C, Weber G, Kvanta E, Lewis K, Janson M, Jones C, Glaser T, Evans G, Nordenskjöld M (1992) Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus. Hum Genet 89:187-193
9. Meldrum E, Parker PJ, Carozzi A (1991) The Pt Ins PLC superfamily and signal transduction. Biochim Biophys Acta 1092: 49-71
10. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:3
11. q-independent activation of phospholipase C β-2. J Biol Chem 267:16048-16055
12. Sinke RJ, Geurts van Kessel A (1995) Localization of the human phosphatidylinositol-specific phospholipase C β3 gene (PLC β3) within chromosome band 11q13. Genomics 25:568-569
13. Weber G, Friedman E, Grimmond S, Hayward NK, Phelan C, Skogseid B, Gobi A, Zedenius I, Sandelin K, Teh BT, Carson E, White I, Öberg K, Shepherd J, Nordenskjöld M, Larsson C (1994) The phospholipase C β3 gene located in the MEN 1 region shows loss of expression in endocrine tumours. Hum Mol Genet 3:1775-1781